This is the authors' abstract. We don't add key points for this paper.
Pinaverium bromide, a calcium channel blocker, is often used in the treatment of the irritable bowel syndrome. Colonie transit time (CTT) was evaluated by a simplified method using radiopaque markers in 19 healthy volunteers during 2 weeks of treatment with pinaverium bromide (50 mg three times a day) or placebo according to a double‐blind crossover design. Pinaverium bromide significantly (p < .05) accelerated total CTT (30.2 ± 4.6 h, mean ± SE) compared with the placebo (38.2 ± 3.7 h). The decrease in CTT was related to accelerated transit in the descending and rectosigmoid areas of the colon (21 ± 4.5 vs. 30 ± 3.9 h, p < .05). CTT in the ascending colon was not significantly modified (9.2 ± 2.7 as compared with 9.5 ± 2.3 h). Stool frequency was not significantly increased by pinaverium bromide. These results suggest that pinaverium bromide might be effective in idiopathic constipation with slow CTT in the descending or rectosigmoid areas of the large bowel. The measurement of CTT is an easy and useful method for investigating the effects of drugs on colonie motility.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Froguel et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: